The Company uses natural tissues and innovative technologies to produce orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Nah nah nah nah....
Nah nah nah nah....
Hey hey hey
Good Buy!
RTI Biologics is a screaming buy at these levels based on the facts I have here. Revenue growth steady at 10-13% per annum, priced well below tangible assets (almost ½ of actual value), 10M more cash than debt and growing earnings (about 16 times 2010), with a technically oversold condition. Did I mention they are in my favorite sector? Medical devices and implants! There is nothing not to like here with RTIX and I think it sees $5 again with ease.
UltraLong